These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3893022)

  • 1. Photon absorptiometry studies in osteoporosis.
    Christiansen C
    Acta Obstet Gynecol Scand Suppl; 1985; 130():67-70. PubMed ID: 3893022
    [No Abstract]   [Full Text] [Related]  

  • 2. Does calcium potentiate the bone-preserving effect of oestrogen treatment in early post-menopausal women by a change in vitamin D metabolism?
    Riis BJ; Christiansen C
    Maturitas; 1984 Jul; 6(1):65-70. PubMed ID: 6381968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxy-vitamin D3 and calcium.
    Jensen GF; Christiansen C; Transbøl I
    Clin Endocrinol (Oxf); 1982 May; 16(5):515-24. PubMed ID: 7044620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trisequens.
    Drug Ther Bull; 1981 Jul; 19(16):63-4. PubMed ID: 7274066
    [No Abstract]   [Full Text] [Related]  

  • 5. Continuous oestrogen-progestogen treatment and bone metabolism in post-menopausal women.
    Riis BJ; Johansen J; Christiansen C
    Maturitas; 1988 May; 10(1):51-8. PubMed ID: 3041248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of postmenopausal bone loss].
    Birkenhäger JC
    Ned Tijdschr Geneeskd; 1985 Jan; 129(3):100-5. PubMed ID: 3885050
    [No Abstract]   [Full Text] [Related]  

  • 7. Does 1,25(OH)2D3 accelerate spinal bone loss? A controlled therapeutic trial in 70-year-old women.
    Jensen GF; Meinecke B; Boesen J; Transbøl I
    Clin Orthop Relat Res; 1985; (192):215-21. PubMed ID: 3881203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum bone Gla protein variations during estrogen and calcium prophylaxis of postmenopausal women.
    Pødenphant J; Christiansen C; Catherwood BD; Deftos LJ
    Calcif Tissue Int; 1984 Sep; 36(5):536-40. PubMed ID: 6441624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause.
    Jensen J; Christiansen C; Rødbro P
    N Engl J Med; 1985 Oct; 313(16):973-5. PubMed ID: 4047104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of 1alpha-hydroxycholecalciferol and hormone therapy on the calcium balance of post-menopausal osteoporosis.
    Marshall DH; Gallagher JC; Guha P; Hanes F; Oldfield W; Nordin BE
    Calcif Tissue Res; 1977 May; 22 Suppl():78-84. PubMed ID: 334349
    [No Abstract]   [Full Text] [Related]  

  • 11. Rationale for active vitamin D and analogs in the treatment of osteoporosis.
    Nishii Y
    J Cell Biochem; 2003 Feb; 88(2):381-6. PubMed ID: 12520540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis.
    Steiniche T; Hasling C; Charles P; Eriksen EF; Mosekilde L; Melsen F
    Bone; 1989; 10(5):313-20. PubMed ID: 2690898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis.
    Christiansen C; Christensen MS; Rødbro P; Hagen C; Transbøl I
    Eur J Clin Invest; 1981 Aug; 11(4):305-9. PubMed ID: 6795047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in bone mineral content in women with natural menopause during treatment with female sex hormones.
    Dalén N; Furuhjelm M; Jacobson B; Lamke B
    Acta Obstet Gynecol Scand; 1978; 57(5):435-7. PubMed ID: 726877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum alkaline phosphatase during hormone treatment in early postmenopausal women. A model for establishing optimal prophylaxis and treatment in postmenopausal osteoporosis.
    Christiansen C; Rødbro P; Tjellesen L
    Acta Med Scand; 1984; 216(1):11-7. PubMed ID: 6385631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous treatment with a combination of estrogen and gestagen--a way of avoiding endometrial stimulation. Clinical experiences with Kliogest.
    Staland B
    Acta Obstet Gynecol Scand Suppl; 1985; 130():29-35. PubMed ID: 3859973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of natural oestrogen/gestagen therapy on uric acid metabolism in post-menopausal women.
    Gotfredsen A; Christiansen C; Transbøl I
    Maturitas; 1983 Jun; 5(1):9-15. PubMed ID: 6348486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The treatment and prevention of premenopausal uterine hemorrhages with Trisequens].
    Rachev E; Katsarova M; Bŭrdarova I
    Akush Ginekol (Sofiia); 1991; 30(2):73-6. PubMed ID: 1883055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study.
    Riis B; Thomsen K; Christiansen C
    N Engl J Med; 1987 Jan; 316(4):173-7. PubMed ID: 3540668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of osteoporosis with 1-alpha-hydroxycholecalciferol and calcium.
    Hoikka V; Alhava EM; Aro A; Karjalainen P; Rehnberg V
    Acta Med Scand; 1980; 207(3):221-4. PubMed ID: 6989171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.